Upcoming Ask the Doc November 3 in Aliso Viejo

screen-shot-2016-10-13-at-12-43-53-pmHave questions about healthy brain aging, memory loss, or Alzheimer’s disease research?
Come to an open forum Q&A session on November 3 at The Covington in Aliso Viejo from 5:30-7:30 pm. UCI MIND is bringing a panel of experts to you at no cost. more >

7th Annual UCI MIND Gala Tickets Released

gala-ml-dedicated-email-version-2Reserve tickets today for the 7th Annual UCI MIND Gala, A December to Remember, on December 3rd at the Balboa Bay Resort in Newport Beach!

Toast the holidays with an elegant evening of dining, dancing, and philanthropy that will have a lasting impact. more >

Alzheimer’s research at UCI “ramps up”

screen-shot-2016-10-03-at-9-26-54-pm“UCI MIND takes multipronged approach to finding preventions, cures in effort to avert baby-boom crisis…”










  more >

UCI MIND Co-Director, Dr. Joshua Grill, advocates for Alzheimer’s research at the U.S. Capitol

Click to view a message from Dr. Grill!

screen-shot-2016-09-22-at-1-00-02-pm more >

Register for next Friday’s conference today!


Education is essential to help increase awareness of Alzheimer’s disease and related dementias. Join us for our biggest education event of the year next Friday, September 30, at the Irvine Marriott. Click here to learn more and register!







  more >

Today is World Alzheimer’s Day!

13522970_1217944214906432_8247924612047374433_oSeptember 21, 2016, is World Alzheimer’s Day!  Learn more about Alzheimer’s disease on our website and help spread the word about the exciting happenings in Alzheimer’s disease research at UCI MIND. more >

The UCI Consent 2 Contact Registry

c2c-old-manResearch is the key to finding treatments and cures for Alzheimer’s disease and other urgent health problems. If you or someone you know is interested in helping researchers at UCI find cures faster, check out our new online potential participant registry, Consent 2 Contact (C2C) more >

Investigational antibody treatment yields exciting though preliminary results

September 1, 2016

A paper published August 31 in Nature, describes that Biogen Idec’s candidate treatment, aducanumab, reduced amyloid-β in the brains of patients with early-stage Alzheimer’s disease. Patients receiving the highest doses of the medicine in the Phase IB trial had the largest reductions in brain amyloid and also declined the least in clinical assessments.

more >

Featured Conference Topic: The Oldest Old, 90+

The EARLYBIRD deadline for the research conference is quickly approaching! Register online before September 9 and SAVE!

90+What allows people to live to age 90 and beyond?

How does memory loss affect those in their 90’s? How do people remain #dementia-free into their 90’s?

more >

Gene Wilder passes away from complications of Alzheimer’s disease

Mandatory Credit: Photo by STEVE WOOD/REX/Shutterstock (74497b) GENE WILDER VARIOUS - 1979

(Steve Wood/Rex/Shutterstock)

August 30, 2016
Huffington Post

We are deeply saddened by the passing of beloved actor Gene Wilder yesterday. His family confirmed Alzheimer’s disease as the cause of death, helping to lift the “veil of stigma about the most common cause of dementia.” more >